Pnc Financial Services Group, Inc. Denali Therapeutics Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 2,905 shares of DNLI stock, worth $70,359. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,905
Previous 2,369
22.63%
Holding current value
$70,359
Previous $55,000
52.73%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding DNLI
# of Institutions
228Shares Held
120MCall Options Held
60.6KPut Options Held
48.4K-
Baillie Gifford & CO13.3MShares$323 Million0.3% of portfolio
-
Black Rock Inc. New York, NY13.2MShares$319 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$271 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$260 Million0.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.91MShares$192 Million0.05% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $3.25B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...